Looking Ahead to a Psychedelic 2023 Post published:February 27, 2023 Post category:2022 Year in Review
COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023 Post published:February 24, 2023 Post category:Press Release
Opinions | Do Mice Hallucinate? Do Humans Head-Twitch? Post published:February 24, 2023 Post category:Opinions
Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023 Post published:February 24, 2023 Post category:Press Release
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT Post published:February 24, 2023 Post category:Press Release
Transcend Therapeutics announces Series A funding round of $40 million Post published:February 23, 2023 Post category:Press Release
MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT Post published:February 22, 2023 Post category:Press Release
Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds Post published:February 22, 2023 Post category:Press Release